CellMEAT, a South Korean lab-grown shrimp producer, bags $8.1M Series A funding

As consumers’ interest in the environment and nutrition rises, food-tech companies join the race to invent meat alternatives. In 2021, alternative seafood companies received $175 million in investment globally, increasing 92% from 2020. A South Korean startup called CellMEAT, which develops cell-based shrimp, has secured $8.1 million (10 billion KRW) Series A funding to compete with 120 companies around the world that produce alternative seafood.

Source: CellMEAT, a South Korean lab-grown shrimp producer, bags $8.1M Series A funding   | TechCrunch

Leave a Comment